“Double-hit” chronic lymphocytic leukemia: An aggressive subgroup with 17p deletion and 8q24 gain-Reference-Cited by-同舟云学术

“Double-hit” chronic lymphocytic leukemia: An aggressive subgroup with 17p deletion and 8q24 gain

Published:2017-12-18 Issue:3 Volume:93 Page:375-382
ISSN:0361-8609
Container-title:American Journal of Hematology
language:en
Short-container-title:Am J Hematol

Author:

Chapiro Elise¹²³^ORCID,Lesty Claude²³,Gabillaud Clémentine³,Durot Eric⁴^ORCID,Bouzy Simon³,Armand Marine¹²³,Le Garff-Tavernier Magali¹³,Bougacha Nadia¹²,Struski Stéphanie⁵,Bidet Audrey⁶,Laharanne Elodie⁶,Barin Carole⁷,Veronese Lauren⁸,Prié Nolwen⁸,Eclache Virginie⁹,Gaillard Baptiste¹⁰,Michaux Lucienne¹¹,Lefebvre Christine¹²,Gaillard Jean-Baptiste¹³,Terré Christine¹⁴,Penther Dominique¹⁵,Bastard Christian¹⁵,Nadal Nathalie¹⁶,Fert-Ferrer Sandra¹⁷,Auger Nathalie¹⁸,Godon Catherine¹⁹,Sutton Laurent²⁰,Tournilhac Olivier²¹,Susin Santos A.¹²,Nguyen-Khac Florence¹²³^ORCID,

Affiliation:

1. INSERM UMR_S 1138, Centre de Recherche des Cordeliers; Paris France

2. Sorbonne Universités, UPMC Paris 6; Paris France

3. Service d'Hématologie Biologique, Hôpital Pitié-Salpêtrière, AP-HP; Paris France

4. Service d'Hématologie Clinique, CHU Reims; Reims France

5. Laboratoire de Cytogénétique, Institut Universitaire du Cancer de Toulouse; Toulouse France

6. CHU Bordeaux, Service d'Hématologie biologique, F-33000; Bordeaux France

7. Unité de Génétique, CHU Bretonneau; Tours France

8. Laboratoire de Cytogénétique, CHU Estaing; Clermont-Ferrand France

9. Laboratoire d'Hématologie, Hôpital Avicenne, AP-HP; Bobigny France

10. Laboratoire d'Hématologie, Hôpital Robert Debré; Reims France

11. Center for Human genetics; Leuven Belgium

12. Laboratoire de Cytogénétique Onco-hématologique, CHU Grenoble; Grenoble France

13. Laboratoire de Cytogénétique, CHU Caremeau; Nimes France

14. Centre Hospitalier de Versailles; Laboratoire de Cytogénétique; Versailles France

15. Laboratoire de Génétique Oncologique, centre de lutte contre le cancer Henri Becquerel; Rouen France

16. Service de génétique chromosomique et moléculaire, CHU Dijon; Dijon France

17. Centre Hospitalier Métropole Savoie; Laboratoire de Génétique Chromosomique; France, Chambéry

18. Laboratoire de Cytogénétique, Institut Gustave Roussy; Villejuif France

19. Laboratoire de Cytogénétique Hématologique, CHU Nantes; Nantes France

20. Centre Hospitalier Métropole Savoie; Service d'Hématologie Clinique; Chambéry France

21. Service d'Hématologie Clinique, CHU Estaing; Clermont-Ferrand France

Funder

Fondation ARC pour la Recherche sur le Cancer

Publisher

Wiley

Subject

Hematology

Reference38 articles.

1. Genomic aberrations and survival in chronic lymphocytic leukemia;Dohner;N Engl J Med.,2000

2. Addition of rituximab to fludarabine and cyclophosphamide in patients with chronic lymphocytic leukaemia: a randomised, open-label, phase 3 trial;Hallek;Lancet.,2010

3. Loss of TP53 is due to rearrangements involving chromosome region 17p10 approximately p12 in chronic lymphocytic leukemia;Fink;Cancer Genet Cytogenet.,2006

4. Chromosomal translocations and karyotype complexity in chronic lymphocytic leukemia: a systematic reappraisal of classic cytogenetic data;Baliakas;Am J Hematol.,2014

5. Acquired genomic copy number aberrations and survival in chronic lymphocytic leukemia;Ouillette;Blood.,2011

Cited by 14 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Acquired Ring Chromosomes in Tumors of Hematopoietic and Lymphoid Tissues;Human Ring Chromosomes;2024

2. Cytogenetics in the management of chronic lymphocytic leukemia: Guidelines from the Groupe Francophone de Cytogénétique Hématologique (GFCH);Current Research in Translational Medicine;2023-10

3. del(8p) and TNFRSF10B loss are associated with a poor prognosis and resistance to fludarabine in chronic lymphocytic leukemia;Leukemia;2023-09-26

4. Duplication of 8q24 in Chronic Lymphocytic Leukemia: Cytogenetic and Molecular Biologic Analysis of MYC Aberrations;Frontiers in Oncology;2022-06-24

5. Monomorphic epitheliotropic intestinal T-cell lymphoma comprises morphologic and genomic heterogeneity impacting outcome;Haematologica;2022-06-16